Range Low Price High Price Comment
30 days $17.56 $26.56 Thursday, 28th Mar 2024 ACAD stock ended at $18.49. This is 1.59% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 2.49% from a day low at $18.05 to a day high of $18.50.
90 days $17.56 $31.82
52 weeks $17.56 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2023-11-02 $22.91 $23.02 $22.50 $22.99 1 555 942
2023-11-01 $22.67 $23.00 $22.36 $22.92 1 576 248
2023-10-31 $22.05 $23.00 $21.94 $22.57 1 171 765
2023-10-30 $21.97 $22.40 $21.90 $22.23 811 536
2023-10-27 $22.57 $22.69 $21.65 $21.76 1 157 456
2023-10-26 $22.56 $22.99 $22.00 $22.50 1 585 258
2023-10-25 $22.76 $22.87 $22.37 $22.59 796 050
2023-10-24 $22.76 $23.05 $22.47 $22.98 910 128
2023-10-23 $22.08 $22.82 $22.08 $22.28 1 586 352
2023-10-20 $23.06 $23.29 $21.97 $22.16 2 379 272
2023-10-19 $23.36 $23.37 $22.88 $22.93 1 255 036
2023-10-18 $23.35 $23.54 $23.00 $23.21 1 361 947
2023-10-17 $24.08 $24.60 $23.39 $23.40 1 380 497
2023-10-16 $23.09 $23.81 $22.86 $23.78 1 245 483
2023-10-13 $22.64 $23.14 $22.08 $23.14 1 226 978
2023-10-12 $23.25 $23.25 $22.38 $22.64 1 812 421
2023-10-11 $23.43 $23.71 $23.31 $23.38 1 136 572
2023-10-10 $23.12 $23.80 $22.87 $23.42 2 397 283
2023-10-09 $21.48 $21.91 $21.32 $21.74 886 318
2023-10-06 $21.11 $21.84 $21.03 $21.68 1 082 155
2023-10-05 $21.62 $22.02 $21.48 $21.96 1 073 621
2023-10-04 $20.61 $21.65 $20.60 $21.52 1 512 347
2023-10-03 $21.34 $21.41 $20.66 $20.78 1 318 078
2023-10-02 $20.69 $21.52 $20.31 $21.47 2 237 375
2023-09-29 $21.64 $21.64 $20.54 $20.84 2 752 309
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT